The US Food and Drug Administration (FDA) has authorised Medrobotics to market its Flex Robotic system in the US.

Pittsburgh Life Sciences Greenhouse (PLSG) is a pure life sciences investment firm, and includes Medrobotics as one of its portfolio companies.

The system offers physicians the ability to access anatomical locations that were difficult or impossible to reach through minimally invasive procedures.

PLSG president John Manzetti said: "I couldn’t be more pleased or more proud of Medrobotics.

"The system offers physicians the ability to access anatomical locations that were difficult or impossible to reach through minimally invasive procedures."

"They were founded by PLSG with their first investment back in 2007 and since then, have continued to advance their business and their patient-centric solutions in ways that will make a tremendous impact on our society."

Designed to quickly integrate into the OR and the surgeon’s practice, the system allows hospitals to expand the patient population that they serve and improve the productivity of their facilities.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Medrobotics president Dr Samuel Straface said: "They recognised not only the potential of our company, but also the Flex Robotics system early-on and have been a key proponent in providing the resources we needed to help us deliver our innovative technology to the masses."

Capable of navigating nearly a 180° path to reach challenging surgical targets, the 3mm articulating instruments can be deployed from a stable surgical platform that extends surgeons’ reach to perform procedures.

The system also features onboard HD visualisation to provide surgeons with a clear view of the navigation path and surgical site, as well as two working channels to accept a broad spectrum of surgical and interventional instruments.